Filtered By:
Condition: Diabetes
Drug: Tarceva

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

Interaction of the EGF Receptor and the Hippo Pathway in the Diabetic Kidney
Activation of the EGF receptor (EGFR) or the Hippo signaling pathway can control cell proliferation, apoptosis, and differentiation, and the dysregulation of these pathways can contribute to tumorigenesis. Previous studies showed that activation of EGFR signaling in renal epithelial cells can exacerbate diabetic kidney injury. Moreover, EGFR has been implicated in regulating the Hippo signaling pathway in Drosophila; thus, we examined this potential interaction in mammalian diabetic kidney disease. Yes-associated protein (YAP) is a transcriptional regulator regulated by the Hippo signaling pathway. We found YAP protein exp...
Source: Journal of the American Society of Nephrology : JASN - May 30, 2016 Category: Urology & Nephrology Authors: Chen, J., Harris, R. C. Tags: Basic Research Source Type: research